Evaluation of Pupillometry for cyp2d6 Phenotyping in Children Treated With Tramadol (PUPICYP)
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated With Tramadol
Sponsor: University Hospital, Geneva
Terminated
difficulties in recruitment
Other terminated trials from University Hospital, Geneva
This NA trial investigates Cytochrome P450 CYP2D6 Enzyme Deficiency and Drug Effect and is currently terminated or withdrawn. University Hospital, Geneva leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2022 — Dec 2022 [monthly]
Recruiting NA
-
May 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2019 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Geneva
For direct contact, visit the study record on ClinicalTrials.gov .